Warrior CARE: Naturalistic Observation and Harm Reduction

Withdrawn before enrolling · Not applicable

Conditions studied: Post Traumatic Stress Disorder, Cannabis Use, Suicide

In brief

This study is looking at therapeutic potential of reducing Tetrahydrocannabinol (THC) levels in regular cannabis smokers using contingency management (CM) intervention in a U.S. veteran population with post-traumatic stress disorder (PTSD).

Key facts

Study ID

NCT05386862

Run by

Wayne State University

People needed

0

Starts

2022-07-13

Expected to finish

2024-01-25

Last updated by the study team

2024-05-03

Who can join

Age: 19 and older, up to 69. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• able to provide informed consent, IQ Score >80,
• served in branch of the US armed forces, report using cannabis,
• report using cannabis (at least 4x/month)
• test positive for THC in urine drug screen,
• meet DSM-5 criteria for PTSD w/ Sx of at least 6 months duration

You may not qualify if…

• urine drug screen positive for any other drugs
• any clinically significant medical problems,
• any current or past serious psychotic or bipolar disorder diagnosis as determined by SCID-5
• at immediate high risk for suicide based on the C-SSRS
• current SUD other than Nicotine Use Disorder, Alcohol (mild or moderate) and Cannabis Use Disorder
• seeking treatment for Cannabis Use Disorder

Where it is running

• Tolan Park Medical Building — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.